Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection.
Congenital human parvovirus B19 infection presented in this case as nonimmune hydrops fetalis that resulted from aplastic anemia at 20 weeks' gestation. Intravascular transfusion therapy led to resolution of the hydrops and a term delivery of an appropriately grown neonate.
Sahakian
V
V
Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City 52242.
Weiner
C P
CP
Naides
S J
SJ
Williamson
R A
RA
Scharosch
L L
LL
D000328:Adult; D001805:Blood Transfusion, Intrauterine; D005260:Female; D005312:Fetal Blood; D006400:Hematocrit; D006801:Humans; D015160:Hydrops Fetalis / Q000382:microbiology* / Q000628:therapy; D010322:Parvoviridae Infections / Q000382:microbiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D016216:Ultrasonography, Prenatal